Rapid and long-lasting efficacy of high-dose ambroxol therapy for neuronopathic Gaucher disease: A case report and literature review.

Mol Genet Genomic Med · 2024 · PMC10980885 · PMID 38553911

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

In addition, serum glucosylsphingosine (Lyso‐Gb1) showed a decreasing trend from 720.7 ng/mL (health control; 3.8) at the beginning of treatment to 129.7 ng/mL at 5 months after the start of treatment.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.